| Net Cash Provided by (Used in) Operating Activities |
$3,519 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$25,234 |
USD |
-178% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
182,370,497 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$21,715 |
USD |
-1234% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$4,664,887 |
USD |
0.26% |
Q2 2025 |
Q2 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$4,664,887 |
USD |
0.26% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$17,941,874 |
USD |
0.26% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Issued |
1 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$19,206,627 |
USD |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
1 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |